Patents by Inventor Li Qiao

Li Qiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250057841
    Abstract: The present invention relates methods for treating thyroid cancer, renal cell carcinoma or hepatocellar carcinoma comprising orally administering to a patient in need of such therapy a therapeutic amount of cabozantinib lauryl sulfate salt, preferably in a capsule form. The method allows the administration of the therapeutic amount of cabozantinib lauryl sulfate salt in a fed state or a fasted state and the administration does not exhibit a food effect.
    Type: Application
    Filed: October 30, 2024
    Publication date: February 20, 2025
    Applicant: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K.C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Publication number: 20250049797
    Abstract: The present invention relates methods for treating thyroid cancer, renal cell carcinoma or hepatocellar carcinoma comprising orally administering to a patient in need of such therapy a therapeutic amount of cabozantinib lauryl sulfate salt, preferably in a capsule form. The method allows the administration of the therapeutic amount of cabozantinib lauryl sulfate salt in a fed state or a fasted state and the administration does not exhibit a food effect.
    Type: Application
    Filed: October 30, 2024
    Publication date: February 13, 2025
    Applicant: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K.C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Publication number: 20240366603
    Abstract: The present invention relates methods for treating chronic myeloid leukemia and/or lymphoblastic leukemia by orally administering to a patient in need of such a therapeutic amount of dasatinib lauryl sulfate salt, preferably in a tablet, capsule or suspension form. The method allows the administration of the therapeutic amount of dasatinib lauryl sulfate salt a fed state or a fasted state and the administration does not exhibit a food effect.
    Type: Application
    Filed: July 19, 2024
    Publication date: November 7, 2024
    Applicant: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K.C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Patent number: 12098848
    Abstract: A combustion method is disclosed, which includes the steps of mixing fuel and an oxidizer into a mixture, wherein fuel originates from a fuel manifold and the oxidizer originates from an oxidizer manifold, and combusting the mixture in a combustion chamber, the fuel manifold, the oxidizer manifold, and the combustion chamber forming parts of an injector assembly wherein each of the fuel and oxidizer manifolds communicates with the combustion chamber via a plurality of dedicated radially disposed Tesla valves around the combustion chamber each via a corresponding port with only one Tesla valve between the fuel manifold and the corresponding port on the combustion chamber and with only one Tesla valve between the oxidizer manifold and the corresponding port on the combustion chamber, wherein the plurality of Tesla valves substantially eliminate reverse flow of exhaust gases from the combustion chamber back to the fuel manifold or the oxidizer manifold.
    Type: Grant
    Filed: September 26, 2023
    Date of Patent: September 24, 2024
    Assignee: Purdue Research Foundation
    Inventors: Qili Liu, Li Qiao
  • Patent number: 12064430
    Abstract: The present invention relates to cabozantinib lauryl sulfate salt and methods of use.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: August 20, 2024
    Assignee: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Patent number: 12064428
    Abstract: The present invention relates to capsules comprising dasatinib lauryl sulfate salt.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: August 20, 2024
    Assignee: HANDA ONCOLOGY, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Publication number: 20240019126
    Abstract: A combustion method is disclosed, which includes the steps of mixing fuel and an oxidizer into a mixture, wherein fuel originates from a fuel manifold and the oxidizer originates from an oxidizer manifold, and combusting the mixture in a combustion chamber, the fuel manifold, the oxidizer manifold, and the combustion chamber forming parts of an injector assembly wherein each of the fuel and oxidizer manifolds communicates with the combustion chamber via a plurality of dedicated radially disposed Tesla valves around the combustion chamber each via a corresponding port with only one Tesla valve between the fuel manifold and the corresponding port on the combustion chamber and with only one Tesla valve between the oxidizer manifold and the corresponding port on the combustion chamber, wherein the plurality of Tesla valves substantially eliminate reverse flow of exhaust gases from the combustion chamber back to the fuel manifold or the oxidizer manifold.
    Type: Application
    Filed: September 26, 2023
    Publication date: January 18, 2024
    Applicant: Purdue Research Foundation
    Inventors: Qili Liu, Li Qiao
  • Patent number: 11788182
    Abstract: A hydrogen-free carbon film polymer lubricating material and a preparation method and use thereof are disclosed. In the method, a graphite target is used as the target material, and a magnetron sputtering deposition is performed on a surface of the polymer substrate, thereby physically depositing and forming a hydrogen-free carbon film on the surface of the polymer substrate, thereby obtaining a hydrogen-free carbon film polymer lubricating material.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: October 17, 2023
    Assignee: Lanzhou Institute of Chemical Physics Chinese Academy of Sciences
    Inventors: Peng Wang, Liqiang Chai, Li Qiao, Xiaogang Bai, Xiaoyu Zhao
  • Patent number: 11767979
    Abstract: A rotating detonation engine (RDE) is disclosed which includes a housing, an injector assembly disposed within the housing, the injector assembly includes a fuel manifold, an oxidizer manifold, and a combustion chamber, fuel from the fuel manifold and an oxidizer from the oxidizer manifold are combined and combusted in the combustion chamber, each of the fuel and oxidizer manifolds communicates with the combustion chamber via a plurality of Tesla valves each via a corresponding port, wherein the plurality of Tesla valves substantially eliminate reverse flow of exhaust gases from the combustion chamber back to the fuel manifold or the oxidizer manifold.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 26, 2023
    Assignee: Purdue Research Foundation
    Inventors: Qili Liu, Li Qiao
  • Publication number: 20230190762
    Abstract: The present invention relates to a stable varenicline solid oral dosage form.
    Type: Application
    Filed: February 13, 2023
    Publication date: June 22, 2023
    Applicant: Handa Pharma, Inc.
    Inventors: Michael He, Zhang Yu, Li Qiao, Stephen Cary
  • Publication number: 20230142737
    Abstract: The present invention relates to cabozantinib lauryl sulfate salt and methods of use.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 11, 2023
    Applicant: Handa Oncology, LLC
    Inventors: FANG-YU LIU, K. C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Publication number: 20230052627
    Abstract: A hydrogen-free carbon film polymer lubricating material and a preparation method and use thereof are disclosed. In the method, a graphite target is used as the target material, and a magnetron sputtering deposition is performed on a surface of the polymer substrate, thereby physically depositing and forming a hydrogen-free carbon film on the surface of the polymer substrate, thereby obtaining a hydrogen-free carbon film polymer lubricating material.
    Type: Application
    Filed: January 21, 2022
    Publication date: February 16, 2023
    Inventors: Peng WANG, Liqiang CHAI, Li QIAO, Xiaogang BAI, Xiaoyu ZHAO
  • Publication number: 20220403500
    Abstract: The present disclosure relates to a structural coating and preparation method and use thereof. The structural coating provided in the present disclosure includes a titanium transition layer and platinum-hafnium composite structure layers laminated in sequence on a surface of a substrate; the number of the platinum-hafnium composite structure layer is ?3; the platinum-hafnium composite structure layer includes a hafnium layer and a platinum layer laminated in sequence.
    Type: Application
    Filed: November 17, 2021
    Publication date: December 22, 2022
    Inventors: Peng Wang, Li Qiao, Hong Zhang, Xiaogang Bai
  • Publication number: 20220195963
    Abstract: A rotating detonation engine (RDE) is disclosed which includes a housing, an injector assembly disposed within the housing, the injector assembly includes a fuel manifold, an oxidizer manifold, and a combustion chamber, fuel from the fuel manifold and an oxidizer from the oxidizer manifold are combined and combusted in the combustion chamber, each of the fuel and oxidizer manifolds communicates with the combustion chamber via a plurality of Tesla valves each via a corresponding port, wherein the plurality of Tesla valves substantially eliminate reverse flow of exhaust gases from the combustion chamber back to the fuel manifold or the oxidizer manifold.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Applicant: Purdue Research Foundation
    Inventors: Qili Liu, Li Qiao
  • Patent number: 11160805
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: November 2, 2021
    Assignee: HANDA ONOCOLOGY, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Publication number: 20210283133
    Abstract: The present invention relates to capsules comprising dasatinib lauryl sulfate salt.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 16, 2021
    Applicant: HANDA ONCOLOGY, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Patent number: 11052088
    Abstract: The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: July 6, 2021
    Assignee: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Publication number: 20210161895
    Abstract: The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Applicant: Handa Oncology, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Patent number: 11007195
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: May 18, 2021
    Assignee: HANDA ONCOLOGY, LLC
    Inventors: Fang-Yu Liu, K.C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Patent number: D1024134
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: April 23, 2024
    Assignee: Purdue Research Foundation
    Inventors: Qili Liu, Li Qiao